Patient P-01628
Therapy response
Unstable
Tolerance
Deteriorating
GI state
Deteriorating
Inflammatory state
Deteriorating
Nutritional resilience
Declining
Discontinuation risk
41%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 NBL-101 started — Baseline state S20
- Day 72 BR-03 recommended — Behavioural Recommendation BR-03
- Day 73 Patient declined — Not now
- Day 79 Trajectory diverged from prediction — Observed response fell below the model's expected path.
What changed?
Trajectory began diverging from predicted response on Day 79.
Primary contributors, last 14 days
- GI instability+17
- Nutritional resilience-17
- Toxicity+10
- Inflammatory activity+7
- Treatment adherence-2
What helped?
- Behavioural Recommendation BR-03Day 72Declined by patient
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
GI burden
Companion26.2/100
worsening · +12.8 vs previous 14 d
Toxicity
Blood27.6/100
worsening · +3.0 vs previous 14 d
Sleep quality
Wearable48.8/100
worsening · -9.0 vs previous 14 d
Energy level
Daily log5.1/10
worsening · -1.3 vs previous 14 d
Stress level
Daily log4.9/10
worsening · +0.8 vs previous 14 d
Steps
Wearable6,876
worsening · -940 vs previous 14 d
Adherence
Companion90 %
stable · +2.0 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →Heading towards failing · 57 from the failing basin, 54 from restoration.
Would help
- No untried action with strong evidence. Compose one from primitives.
Would not help
- Keep alcohol lowGI +4.8 next day on high-intake days · n 20
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Alcohol+4.8detractor · 95%
- Spicy / capsaicin+1.6no signal · 25%
- Dietary fat load+1.4no signal · 21%
- Insoluble fibre-1.2no signal · 22%
- Histamine load+1.1no signal · 22%
- Simple carbohydrates0no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Mucosal barrier integrity ↓30
- MicrobiomeAkkermansia low → thinner mucus layer
- Butyrate / short-chain fatty acid production ↓25
- MicrobiomeF. prausnitzii depleted
- Inflammatory signalling ↑15
- WearableHRV 36 ms, trending down
DNA
Fictional pharmacogenomic panel
- CYP2D6 Normal metabolizerExpected exposure
Microbiome
Shannon diversity 3.8 · butyrate capacity 72/100
- Akkermansia muciniphilaLow
- Faecalibacterium prausnitziiLow
- Bacteroides fragilisNormal
- Bifidobacterium longumLow
- EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 32 ms
- Sleep
- 7.4 h
- Steps
- 6,093
- Resting HR
- 64 bpm
Daily log: GI score 26, nutritional resilience 58, adherence 90.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
- Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
- Log the daily check-in; one line is enough
- Keep the current walking rhythm
- Keep the sleep window steady
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the scheduled dose as agreed with your care team
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.